<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03929289</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0268</org_study_id>
    <secondary_id>2019-A01027-50</secondary_id>
    <nct_id>NCT03929289</nct_id>
  </id_info>
  <brief_title>The Visuo-attentional Mediator of Social Facilitation</brief_title>
  <acronym>VAMOS</acronym>
  <official_title>The Visuo-attentional Mediator of Social Facilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Social psychology has long established that the mere presence of others influences the
      investigator's individual behavior and performance. &quot;Social facilitation&quot; refers to any
      improvement or deterioration of performance due to the presence of others. For more than a
      century, social psychology has acquired a solid knowledge of the principles governing this
      fundamental form of social influence.

      But the underlying mechanism of social facilitation remains debated, as behavior alone cannot
      identify it with certainty. This major unresolved problem makes it particularly difficult to
      translate laboratory results on social facilitation into real applications in areas such as
      school or work, where others are ubiquitous. The purpose of this study will therefore be to
      identify the mediator of social facilitation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activation</measure>
    <time_frame>50 minutes</time_frame>
    <description>Cerebral Blood Oxygenation Level-Dependent (BOLD) signals</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>pupillary diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>error rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>reaction time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>oculomotor kinematic parameters: velocity of saccades.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>oculomotor kinematic parameters: duration of saccades.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral performances</measure>
    <time_frame>50 minutes</time_frame>
    <description>oculomotor kinematic parameters: precision of saccades.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Social Facilitation</condition>
  <arm_group>
    <arm_group_label>Social Facilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive tasks during functional Magnetic Resonance Imaging (fMRI) observed or not by a subject's known peer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Facilitation</intervention_name>
    <description>During the functional Magnetic Resonance Imaging (fMRI) scan, the subject will perform cognitive tasks measuring eye movements and attention alternatively observed by a familiar peer (in an adjacent room) or not.</description>
    <arm_group_label>Social Facilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female

          -  Aged 18 to 35 years old

          -  Signed written informed consent

          -  Insurance coverage

        Exclusion Criteria:

          -  Neurological or psychiatric or ophthalmological disorder

          -  Non-stabilized medical condition

          -  Ongoing treatment with drugs that affect the central nervous system

               -  Uncorrected visual inadequacy

               -  No fluency in French reading

               -  Pregnant and / or breastfeeding woman, this exclusion criterion will be sought by
                  questioning the subject

               -  Subject commonly in care in a health or social facility for purposes other than
                  that of research

               -  Subject under guardianship

               -  Subject deprived of liberty by a judicial or administrative decision

               -  Incompatibility with the Magnetic Resonance Imaging (MRI) examination determined
                  by answering the following questions:

          -  Carrier of a neurological stimulator, cardiac (battery) or defibrillator

          -  Carrier of a cardiac prosthesis (valve, stent ...) or vascular

          -  Holder of intracranial clips or clamps (staples)

          -  Carrier of a cerebrospinal fluid bypass

          -  Presence of metal chips in the eyes

          -  Metal prosthesis carrier (teeth, knees)

          -  Pump carrier or infusion system

          -  Presence of metal tattoo near the head

          -  Presence of permanent makeup

          -  Claustrophobia or respiratory disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denis PELISSON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche en Neuroscience de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denis PELISSON, MD</last_name>
    <phone>4 72 91 34 17</phone>
    <phone_ext>+33</phone_ext>
    <email>denis.pelisson@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martine MEUNIER, MD</last_name>
    <phone>4 72 91 34 17</phone>
    <phone_ext>+33</phone_ext>
    <email>martine.meunier@inserm.fr</email>
  </overall_contact_backup>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>April 12, 2019</study_first_submitted>
  <study_first_submitted_qc>April 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2019</study_first_posted>
  <last_update_submitted>August 7, 2019</last_update_submitted>
  <last_update_submitted_qc>August 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Functional Magnetic Resonance Imaging (fMRI)</keyword>
  <keyword>Healthy Subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

